Increased tilt-cage activity after serotonin depletion by 5,7-dihydroxytryptamine.
D015116:5,7-Dihydroxytryptamine / Q000494:pharmacology*; D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D002940:Circadian Rhythm; D004102:Dihydroxytryptamines / Q000494:pharmacology*; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects*; D011903:Raphe Nuclei / Q000502:physiology; D051381:Rats; D012701:Serotonin / Q000378:metabolism* / Q000502:physiology; D013997:Time Factors
D001679:Biogenic Amines; D004102:Dihydroxytryptamines; D015116:5,7-Dihydroxytryptamine; D012701:Serotonin; D010134:Fenclonine